Fred Aslan
Director & Chief Executive Officer
SEC EDGAR ↗Director & Chief Executive Officer at Artiva Biotherapeutics, Inc., filing insider transactions between 2025-08-15 and 2026-05-19.
Total Purchases
—
0 transactions
Total Sales
$507K
5 transactions
Companies Traded
1
5 total filings
Active Since
2025-08-15
Last: 2026-05-19
Other Reporting Insiders at Artiva Biotherapeutics, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-05-19 | ARTV | Sale | 27.1K | $9.01 | $244K | 1.54M | SEC ↗ |
| 2025-12-15 | ARTV | Sale | 3,187 | $6.00 | $19K | 1.21M | SEC ↗ |
| 2025-11-17 | ARTV | Sale | 6,375 | $3.38 | $22K | 344.0K |
Chief Tech Operations Officer
Fred Aslan (Artiva Biotherapeutics, Inc.) Insider Trades | Tormere